IP Verse

Formulations Of Mazindol - EP2552210B1

PatentPatent Analysis

EP2552210

SUPERNUS PHARMACEUTICALS
Application Number
EP11763348A
Filing Date
Mar 30, 2011
Status
Revoked
Mar 29, 2024
Grant Date
Dec 20, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP1589951B1

Bibliography

The patent EP2552210B1 was granted to Supernus Pharmaceuticals on Dec 20, 2017 following the initial filing on Mar 30, 2011 under the application number EP11763348A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

REGIMBEAUSep 20, 2018ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents